Finance

Beta
Lists
BCYC:NASDAQ
Bicycle Therapeutics PLC
$4.17
-0.71%
(-0.030) 1D
Jun 8, 12:05:05 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BCYC...
Open
$4.23
High
$4.26
Low
$4.14
Mkt. cap
290.41M
Avg. vol.
338.70K
Volume
152.85K
52-wk high
$9.36
52-wk low
$4.08
EPS
-$3.16
Beta
1.54
Shares outstanding
50.37M
No. of employees
288
Open
$4.23
High
$4.26
Low
$4.14
Mkt. cap
290.41M
Avg. vol.
338.70K
Volume
152.85K
52-wk high
$9.36
52-wk low
$4.08
EPS
-$3.16
Beta
1.54
Shares outstanding
50.37M
No. of employees
288
Analyst outlook
Analyst Ratings
Based on 8 analysts giving stock ratings to BCYC in the past 3 months
Buy
Buy
5
Hold
3
Sell
0
12 month forecast
Based on 8 Wall Street analysts offering 12 month price targets for BCYC in the last 3 months.
Highest
Current $4.17
$36.00 (+763.31%)
Average
$13.57 (+225.42%)
Lowest
$5.00 (+19.90%)
News stories
From sources across the web
About Bicycle Therapeutics PLC
CEOKevin Lee
Employees288
Founded2009
Headquarters-
SectorBiotechnology
Websitebicycletherapeutics.com
Last report
Apr 30, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
-$0.87 / -$0.71
-23.28%miss
Revenue / Est. (USD)
887.00K / 8.13M
-89.09%miss
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
2.92M
11.73M
47.96M
887.00K
Cost of goods sold
71.03M
56.61M
45.92M
46.96M
Cost of revenue
71.03M
56.61M
45.92M
46.96M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
18.49M
20.67M
22.55M
19.41M
Operating expense
18.49M
20.67M
22.55M
19.41M
Total operating expenses
89.52M
77.28M
68.46M
66.37M
Operating income
-86.60M
-65.55M
-20.51M
-65.48M
Other non operating income
-
-
-
-
EBT including unusual items
-79.18M
-58.90M
-18.89M
-60.65M
EBT excluding unusual items
-79.18M
-58.90M
-14.69M
-60.65M
Income tax expense
-231.00K
205.00K
1.26M
172.00K
Effective tax rate
0.29%
-0.35%
-6.70%
-0.28%
Other operating expenses
-
-
-
-
Net income
-78.95M
-59.10M
-20.15M
-60.82M
Net profit margin
-2,703.84%
-503.66%
-42.03%
-6,857.38%
Earnings per share
-1.14
-0.85
-0.29
-0.87
Interest and investment income
7.47M
6.70M
5.88M
4.88M
Interest expense
-54.00K
-44.00K
-57.00K
-48.00K
Net interest expenses
7.42M
6.66M
5.82M
4.83M
Depreciation and amortization charges
-
-
-
-
EBITDA
-84.91M
-63.80M
-19.17M
-64.35M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer